ATA173599A - Pharmazeutisches produkt - Google Patents

Pharmazeutisches produkt

Info

Publication number
ATA173599A
ATA173599A AT0173599A AT173599A ATA173599A AT A173599 A ATA173599 A AT A173599A AT 0173599 A AT0173599 A AT 0173599A AT 173599 A AT173599 A AT 173599A AT A173599 A ATA173599 A AT A173599A
Authority
AT
Austria
Prior art keywords
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
AT0173599A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Eli Lilly Ges M B H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Eli Lilly Ges M B H filed Critical Lilly Co Eli
Priority to AT0173599A priority Critical patent/ATA173599A/de
Priority to ARP000105329A priority patent/AR026002A1/es
Priority to EP00969051A priority patent/EP1220674A1/de
Priority to PCT/AT2000/000265 priority patent/WO2001026662A1/de
Priority to CO00077920A priority patent/CO5251422A1/es
Priority to AU78878/00A priority patent/AU7887800A/en
Publication of ATA173599A publication Critical patent/ATA173599A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0173599A 1999-10-14 1999-10-14 Pharmazeutisches produkt ATA173599A (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT0173599A ATA173599A (de) 1999-10-14 1999-10-14 Pharmazeutisches produkt
ARP000105329A AR026002A1 (es) 1999-10-14 2000-10-10 Producto farmaceutico.
EP00969051A EP1220674A1 (de) 1999-10-14 2000-10-12 Pharmazeutische produkte geeignet für die immunsuppressiven therapie
PCT/AT2000/000265 WO2001026662A1 (de) 1999-10-14 2000-10-12 Pharmazeutische produkte geeignet für die immunsuppressiven therapie
CO00077920A CO5251422A1 (es) 1999-10-14 2000-10-12 Producto farmaceutico
AU78878/00A AU7887800A (en) 1999-10-14 2000-10-12 Pharmaceutical product suitable for use immunosuppressive therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0173599A ATA173599A (de) 1999-10-14 1999-10-14 Pharmazeutisches produkt

Publications (1)

Publication Number Publication Date
ATA173599A true ATA173599A (de) 2001-04-15

Family

ID=3519875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0173599A ATA173599A (de) 1999-10-14 1999-10-14 Pharmazeutisches produkt

Country Status (6)

Country Link
EP (1) EP1220674A1 (de)
AR (1) AR026002A1 (de)
AT (1) ATA173599A (de)
AU (1) AU7887800A (de)
CO (1) CO5251422A1 (de)
WO (1) WO2001026662A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016523818A (ja) * 2013-04-18 2016-08-12 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル それを必要とする被験体におけるｔ細胞増殖を阻害するための方法及び医薬組成物（ｃｔｐｓ１阻害剤、例えばノルロイシン）

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010397A1 (de) * 1980-03-18 1981-10-29 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
TW466112B (en) * 1998-04-14 2001-12-01 Lilly Co Eli Novel use of 2'-deoxy-2',2'-difluorocytidine for immunosuppressive therapy and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
WO2001026662A1 (de) 2001-04-19
AR026002A1 (es) 2002-12-26
CO5251422A1 (es) 2003-02-28
EP1220674A1 (de) 2002-07-10
AU7887800A (en) 2001-04-23

Similar Documents

Publication Publication Date Title
DE69903605D1 (de) Verpacktes produkt
NO953657D0 (no) Nytt farmasöytisk produkt
ATE411068T1 (de) Medikamentspender
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
NO20015175D0 (no) Farmasöytisk sammensetning
DE60010089D1 (de) Beta-carbolin arzneistoffprodukte
DK1073417T3 (da) Farmaceutisk aerosolformulering
NO20011360D0 (no) Granulært produkt
NO20015670L (no) Forbedrede farmasöytiske formuleringer
FI20000976A7 (fi) Tuotteita
PT1173434E (pt) Novo produto farmaceutico
NO20022606L (no) Farmasöytiske kombinasjoner
NO20014133D0 (no) Rokbart produkt
DE60203279D1 (de) Selbstschäumendes kosmetisches produkt
NO20014926D0 (no) Farmasöytiske forbindelser
DE69931709D1 (de) Absorbierendes Produkt
AR025867A1 (es) Formulacion portasdora farmaceutica
FI4488U1 (fi) Farmaseuttinen koostumus
NO20016430D0 (no) Farmasöytisk kompleks
NO991013L (no) Krystallinsk farmas°ytisk produkt
NO991359D0 (no) Tablettdispenser
UA3475S (uk) Пляшка для лікеро-горілчаного виробу
UA3476S (uk) Пляшка для лікеро-горілчаного виробу
FI991355A0 (fi) Vähätoksinen tupakkatuote
SE9904282D0 (sv) Dietary product

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
A1J Withdrawal paragraph 166 lit. 6